Literature DB >> 33488959

Steering New Drug Discovery Campaigns: Permeability, Solubility, and Physicochemical Properties in the bRo5 Chemical Space.

Giulia Caron1, Jan Kihlberg2, Gilles Goetz3, Ekaterina Ratkova4, Vasanthanathan Poongavanam2, Giuseppe Ermondi1.   

Abstract

An increasing number of drug discovery programs concern compounds in the beyond rule of 5 (bRo5) chemical space, such as cyclic peptides, macrocycles, and degraders. Recent results show that common paradigms of property-based drug design need revision to be applied to larger and more flexible compounds. A virtual event entitled "Solubility, permeability and physico-chemical properties in the bRo5 chemical space" was organized to provide preliminary guidance on how to make the discovery of oral drugs in the bRo5 space more effective. The four speakers emphasized the importance of the bRo5 space as a source of new oral drugs and provided examples of experimental and computational methods specifically tailored for design and optimization in this chemical space.
© 2021 American Chemical Society.

Entities:  

Year:  2021        PMID: 33488959      PMCID: PMC7812602          DOI: 10.1021/acsmedchemlett.0c00581

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  55 in total

1.  Lipophilic Permeability Efficiency Reconciles the Opposing Roles of Lipophilicity in Membrane Permeability and Aqueous Solubility.

Authors:  Matthew R Naylor; Andrew M Ly; Mason J Handford; Daniel P Ramos; Cameron R Pye; Akihiro Furukawa; Victoria G Klein; Ryan P Noland; Quinn Edmondson; Alexandra C Turmon; William M Hewitt; Joshua Schwochert; Chad E Townsend; Colin N Kelly; Maria-Jesus Blanco; R Scott Lokey
Journal:  J Med Chem       Date:  2018-12-11       Impact factor: 7.446

2.  High throughput method for the indirect detection of intramolecular hydrogen bonding.

Authors:  Gilles H Goetz; William Farrell; Marina Shalaeva; Simone Sciabola; Dennis Anderson; Jiangli Yan; Laurence Philippe; Michael J Shapiro
Journal:  J Med Chem       Date:  2014-03-31       Impact factor: 7.446

3.  New Chemical Modalities and Strategic Thinking in Early Drug Discovery.

Authors:  Maria-Jesus Blanco; Kevin M Gardinier
Journal:  ACS Med Chem Lett       Date:  2020-01-14       Impact factor: 4.345

4.  "Flexible-Acceptor" General Solubility Equation for beyond Rule of 5 Drugs.

Authors:  Alex Avdeef; Manfred Kansy
Journal:  Mol Pharm       Date:  2020-09-04       Impact factor: 4.939

5.  Why Some Targets Benefit from beyond Rule of Five Drugs.

Authors:  Megan Egbert; Adrian Whitty; György M Keserű; Sandor Vajda
Journal:  J Med Chem       Date:  2019-06-26       Impact factor: 7.446

6.  Discovery of Potent and Orally Bioavailable Macrocyclic Peptide-Peptoid Hybrid CXCR7 Modulators.

Authors:  Markus Boehm; Kevin Beaumont; Rhys Jones; Amit S Kalgutkar; Liying Zhang; Karen Atkinson; Guoyun Bai; Janice A Brown; Heather Eng; Gilles H Goetz; Brian R Holder; Bhagyashree Khunte; Sarah Lazzaro; Chris Limberakis; Sangwoo Ryu; Michael J Shapiro; Laurie Tylaska; Jiangli Yan; Rushia Turner; Siegfried S F Leung; Mahesh Ramaseshan; David A Price; Spiros Liras; Matthew P Jacobson; David J Earp; R Scott Lokey; Alan M Mathiowetz; Elnaz Menhaji-Klotz
Journal:  J Med Chem       Date:  2017-10-30       Impact factor: 7.446

7.  Updating the portfolio of physicochemical descriptors related to permeability in the beyond the rule of 5 chemical space.

Authors:  Giuseppe Ermondi; Maura Vallaro; Gilles Goetz; Marina Shalaeva; Giulia Caron
Journal:  Eur J Pharm Sci       Date:  2020-02-20       Impact factor: 4.384

8.  Rationalization of the Membrane Permeability Differences in a Series of Analogue Cyclic Decapeptides.

Authors:  Jagna Witek; Shuzhe Wang; Benjamin Schroeder; Robin Lingwood; Andreas Dounas; Hans-Jörg Roth; Marianne Fouché; Markus Blatter; Oliver Lemke; Bettina Keller; Sereina Riniker
Journal:  J Chem Inf Model       Date:  2018-12-04       Impact factor: 4.956

9.  Integrating intramolecular hydrogen bonding (IMHB) considerations in drug discovery using ΔlogP as a tool.

Authors:  Marina Shalaeva; Giulia Caron; Yuriy A Abramov; Thomas N O'Connell; Mark S Plummer; Geeta Yalamanchi; Kathleen A Farley; Gilles H Goetz; Laurence Philippe; Michael J Shapiro
Journal:  J Med Chem       Date:  2013-06-12       Impact factor: 7.446

10.  Structure-based design, SAR analysis and antitumor activity of PI3K/mTOR dual inhibitors from 4-methylpyridopyrimidinone series.

Authors:  Hengmiao Cheng; Jacqui E Hoffman; Phuong T Le; Mason Pairish; Robert Kania; William Farrell; Shubha Bagrodia; Jing Yuan; Shaoxian Sun; Eric Zhang; Cathy Xiang; Deepak Dalvie; Sadayappan V Rahavendran
Journal:  Bioorg Med Chem Lett       Date:  2013-02-13       Impact factor: 2.823

View more
  5 in total

Review 1.  A property-response perspective on modern toxicity assessment and drug toxicity index (DTI).

Authors:  Vaibhav A Dixit; Pragati Singh
Journal:  In Silico Pharmacol       Date:  2021-05-15

2.  Polar/apolar interfaces modulate the conformational behavior of cyclic peptides with impact on their passive membrane permeability.

Authors:  Stephanie M Linker; Christian Schellhaas; Benjamin Ries; Hans-Jörg Roth; Marianne Fouché; Stephane Rodde; Sereina Riniker
Journal:  RSC Adv       Date:  2022-02-16       Impact factor: 3.361

Review 3.  Key Considerations in Targeted Protein Degradation Drug Discovery and Development.

Authors:  Liena Qin; Han Dai; Junfeng Wang
Journal:  Front Chem       Date:  2022-08-01       Impact factor: 5.545

Review 4.  A story of peptides, lipophilicity and chromatography - back and forth in time.

Authors:  Vanessa Erckes; Christian Steuer
Journal:  RSC Med Chem       Date:  2022-03-22

5.  Refinement of Computational Access to Molecular Physicochemical Properties: From Ro5 to bRo5.

Authors:  Matteo Rossi Sebastiano; Diego Garcia Jimenez; Maura Vallaro; Giulia Caron; Giuseppe Ermondi
Journal:  J Med Chem       Date:  2022-09-12       Impact factor: 8.039

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.